Skip to main content

JANUS HENDERSON GROUP PLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1274173 LONDON, X0

Position in HALO

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$79,731,316
+$21,587,078 QoQ
Shares Held
1,233,658
+42.8% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 78.55791475433223.ToString("F0")% None 21.442085245667762.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,891,244,813 across 182 Biotechnology names. HALO ranks #37 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $79,731,316 1,233,658
2025-12-31 $58,144,238 863,956
2025-09-30 $70,261,845 958,029
2025-06-30 $47,358,695 910,394
2025-03-31 $45,606,729 714,727
2024-12-31 $33,566,683 702,085
2024-09-30 $31,205,701 545,173
2024-06-30 $26,876,491 513,302
2024-03-31 $21,606,164 531,125
2023-12-31 $15,826,787 428,214
2023-09-30 $16,309,107 426,940
2023-06-30 $15,436,913 427,971
2023-03-31 $16,347,763 428,064
2022-12-31 $36,651,678 644,142
2022-09-30 $27,264,252 689,536
2022-06-30 $30,273,760 688,040
2022-03-31 $29,103,425 729,775
2021-12-31 $27,003,869 671,571
2021-09-30 $26,783,508 658,395
2021-06-30 $29,600,780 651,856
2021-03-31 $28,481,315 683,169
2020-12-31 $34,142,801 799,410
2020-09-30 $23,370,882 889,303